Cargando…

Switching to Pitavastatin in Statin-Treated Low HDL-C Patients Further Improves the Lipid Profile and Attenuates Minute Myocardial Damage

BACKGROUND: The aim of this study is to determine the prevalence of minute myocardial damage (MMD) in already statin-treated dyslipidemic patients with a low high-density lipoprotein-cholesterol (HDL-C) level, and to evaluate whether pitavastatin could affect the lipid profiles and biomarkers reflec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ibuki, Chikao, Seino, Yoshihiko, Otsuka, Toshiaki, Kimata, Nakahisa, Inami, Toru, Munakata, Ryo, Mizuno, Kyoichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elmer Press 2012
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3513420/ https://www.ncbi.nlm.nih.gov/pubmed/23226171 http://dx.doi.org/10.4021/jocmr1108w

Ejemplares similares

Impact of Prediabetic Status on Coronary Atherosclerosis: A multivessel angioscopic study
por: Kurihara, Osamu, et al.
Publicado: (2013)

The Fixed-Dose Combination of Losartan/Hydrochlorothiazide Elicits Potent Blood Pressure Lowering During Nighttime in Obese Hypertensive Patients
por: Ibuki, Chikao, et al.
Publicado: (2014)

Statins in cardiometabolic disease: what makes pitavastatin different?
por: Ginsberg, Henry
Publicado: (2013)

Current perspectives on the use of statins in the treatment of dyslipidaemic patients: focus on pitavastatin
por: Tokgözoglu, Lale, et al.
Publicado: (2020)

Place of pitavastatin in the statin armamentarium: promising evidence for a role in diabetes mellitus
por: Kawai, Yasuyuki, et al.
Publicado: (2011)

Mini-Review on the Efficacy and Safety of Pitavastatin: “The Novel Seventh Statin Gaining Momentum”
por: Ramadan, Azza, et al.
Publicado: (2022)

Effects of pitavastatin on plasminogen activator inhibitor-1 in hyperlipidemic patients
por: Nomura, Shosaku, et al.
Publicado: (2012)

Pleiotropic effects of pitavastatin
por: Davignon, Jean
Publicado: (2012)

Interaction of the pitavastatin with model membranes
por: Shurshalova, Guzel S., et al.
Publicado: (2021)

Microvascular resistance in response to iodinated contrast media in normal and functionally impaired kidneys
por: Kurihara, Osamu, et al.
Publicado: (2015)

Pitavastatin in cardiometabolic disease: therapeutic profile
por: Masana, Luis
Publicado: (2013)

Pitavastatin: evidence for its place in treatment of hypercholesterolemia
por: Alagona, Peter
Publicado: (2010)

Effect of Pitavastatin on Vascular Reactivity in Hypercholesterolemic Rabbits
por: de Almeida, Eros Antonio, et al.
Publicado: (2014)

Efficacy and Safety of Pitavastatin/Ezetimibe Fixed-Dose Combination vs. Pitavastatin: Phase III, Double-Blind, Randomized Controlled Trial
por: Tsujita, Kenichi, et al.
Publicado: (2023)

Effects of intensive versus mild lipid lowering by statins in patients with ischemic congestive heart failure: Korean Pitavastatin Heart Failure (SAPHIRE) study
por: Lee, Hae-Young, et al.
Publicado: (2014)

Pitavastatin and Lovastatin Exhibit Calcium Channel Blocking Activity Which Potentiate Vasorelaxant Effects of Amlodipine: A New Futuristic Dimension in Statin’s Pleiotropy
por: Ali, Wajid, et al.
Publicado: (2023)

The association of HDL-apoCIII with coronary heart disease and the effect of statin treatment on it
por: Xiong, Xiaowei, et al.
Publicado: (2015)

Pitavastatin approved for treatment of primary hypercholesterolemia and combined dyslipidemia
por: Sasaki, Jun
Publicado: (2010)

Pitavastatin suppressed liver cancer cells in vitro and in vivo
por: You, He-Yi, et al.
Publicado: (2016)

Differential Diabetogenic Effect of Pitavastatin and Rosuvastatin, in vitro and in vivo
por: Cho, Yongin, et al.
Publicado: (2020)

Pitavastatin Is a Highly Potent Inhibitor of T-Cell Proliferation
por: Voss, Linda, et al.
Publicado: (2021)

The Priority of Non-HDL-C Assessment to Predict New Lesions among Stable Angina Patients with Strong Statins
por: Kanda, Daisuke, et al.
Publicado: (2022)

Efficacy and Safety of Pitavastatin in a Real-World Setting: Observational Study Evaluating SaFety in Patient Treated with Pitavastatin in Korea (PROOF Study)
por: Jeong, In-Kyung, et al.
Publicado: (2020)

Pitavastatin-Incorporated Nanoparticles for Chronic Limb Threatening Ischemia: A Phase I/IIa Clinical Trial
por: Matsumoto, Takuya, et al.
Publicado: (2022)

Effect of holiday admission for acute aortic dissection on in-hospital mortality in Japan: A nationwide study
por: Kato, Katsuhito, et al.
Publicado: (2021)

Statin-Induced Increase in HDL-C and Renal Function in Coronary Heart Disease Patients(§)
por: Athyros, Vasilios G, et al.
Publicado: (2007)

The Impact of CDH13 Polymorphism and Statin Administration on TG/HDL Ratio in Cardiovascular Patients
por: Choi, Jung Ran, et al.
Publicado: (2015)

Esterification of HDL-cholesterol is Decreased in Diabetes Mellitus and CAD and Enhanced Following Treatment with Statins
por: Bagheri, Babak, et al.
Publicado: (2018)

Beyond Statins: Emerging Evidence for HDL-Increasing Therapies and Diet in Treating Cardiovascular Disease
por: Farrer, Sterling
Publicado: (2018)

Benefit–risk assessment of pitavastatin for the treatment of hypercholesterolemia in older patients
por: Chamberlin, Kevin W, et al.
Publicado: (2015)

Chest pain as a possible side effect of pitavastatin (Livalo)
por: AlZahrani, Nada R., et al.
Publicado: (2019)

Conformational Analysis of Geometric Isomers of Pitavastatin Together with Their Lactonized Analogues
por: Makuc, Damjan, et al.
Publicado: (2013)

Pitavastatin Ameliorates Lipopolysaccharide-Induced Blood-Brain Barrier Dysfunction
por: Fujimoto, Takashi, et al.
Publicado: (2021)

Pitavastatin Induces Cancer Cell Apoptosis by Blocking Autophagy Flux
por: Tilija Pun, Nirmala, et al.
Publicado: (2022)

Very rapid effect of pitavastatin on microvascular function in comparison to rosuvastatin: reactive hyperemia peripheral arterial tonometric study
por: Kono, Yasushi, et al.
Publicado: (2013)

Are Patients with Low Non-HDL Cholesterol “Non-responders” to Statin Therapy on Coronary Plaque Regression?
por: Koba, Shinji
Publicado: (2016)

Geographical predisposition influences on the distribution and tissue characterisation of eccentric coronary plaques in non-branching coronary arteries: cross-sectional study of coronary plaques analysed by intravascular ultrasound
por: Komiyama, Hidenori, et al.
Publicado: (2016)

Critical appraisal of the role of pitavastatin in treating dyslipidemias and achieving lipid goals
por: Saito, Yasushi
Publicado: (2009)

Effects of pitavastatin add-on therapy on chronic kidney disease with albuminuria and dyslipidemia
por: Ohsawa, Masato, et al.
Publicado: (2015)

Pitavastatin nanoparticle-engineered endothelial progenitor cells repair injured vessels
por: Liu, Huanyun, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_igjbb00kd0q03stu2s4glsiokp